Ectodysplasin A2 receptor
Results: 1
# | Item |
---|---|
1 | EDI200 – A Biotherapeutic For Treating X-linked Hypohidrotic Ectodermal Dysplasia (XLHED) Phase 2 clinical study initiated Preclinical data strongly confirms validity of target pathway and therapeutic approachAdd to Reading ListSource URL: edimerpharma.comLanguage: English - Date: 2014-06-05 15:51:36 |